Naturally Occurring Resistance Associated Substitutions in Non-Cirrhotic, Treatment Naive HCV–HIV Co-Infected Patients Does Not Affect the Treatment Response for Anti-HCV Antiviral Therapy

References

• Platt L, Easterbrook P, Gower E, et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):797–808. doi:10.1016/S1473-3099(15)00485-526922272
   PubMed Web of Science ®Google Scholar
• Goel A, Seguy N, Aggarwal R. Burden of hepatitis C virus infection in India: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2019;34(2):321–329. doi:10.1111/jgh.1446630176181
   PubMed Web of Science ®Google Scholar
• Soto B, Sanchez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol. 1997;26(1):1–5. doi:10.1016/S0168-8278(97)80001-3
   PubMed Web of Science ®Google Scholar
• Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology. 1999;30(4):1054–1058. doi:10.1002/hep.51030040910498659
   PubMed Web of Science ®Google Scholar
• Vermehren J, Park JS, Jacobson IM, Zeuzem S. Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection. J Hepatol. 2018;69(5):1178–1187. doi:10.1016/j.jhep.2018.07.00230006068
   PubMed Web of Science ®Google Scholar
• Schlabe S, Rockstroh JK. Advances in the treatment of HIV/HCV coinfection in adults. Expert Opin Pharmacother. 2018;19(1):49–64. doi:10.1080/14656566.2017.141918529252031
   PubMed Web of Science ®Google Scholar
• Piekarska A, Jablonowska E, Garlicki A, et al. Real life results of direct acting antiviral therapy for HCV infection in HIV-HCV-coinfected patients: Epi-Ter2 study. AIDS Care. 2020;32(6):762–769. doi:10.1080/09540121.2019.164580831345052
   PubMed Web of Science ®Google Scholar
• Salmon D, Trimoulet P, Gilbert C, et al. Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients. World J Hepatol. 2018;10(11):856–866. doi:10.4254/wjh.v10.i11.85630533186
   PubMed Web of Science ®Google Scholar
• Huang W, Wang M, Gong Q, et al. Comparison of naturally occurring resistance-associated substitutions between 2008 and 2016 in Chinese patients with chronic hepatitis C virus infection. Microb Drug Resist. 2019;25(6):944–950. doi:10.1089/mdr.2018.036030702389
   PubMed Web of Science ®Google Scholar
• Paolucci S, Fiorina L, Mariani B, et al. Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naive patients. Virol J. 2013;10:355. doi:10.1186/1743-422X-10-35524341898
   PubMed Web of Science ®Google Scholar
• Chen M, Ma Y, Chen H, et al. Multiple Introduction and naturally occuring drug resistance of HCV among HIV-infected intravenous drug users in Yunnan: an origin of China’s HIV/HCV epidemics. PLoS One. 2015;10(11):e0142543. doi:10.1371/journal.pone.014254326562015
   PubMed Web of Science ®Google Scholar
• Ramezani A, Baesi K, Banifazl M, et al. Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population. Clin Res HepatolGastroenterol. 2019;43(5):594–602. doi:10.1016/j.clinre.2019.01.011
   Web of Science ®Google Scholar
• Ministry of Health and Family Welfare; Government of India. National Guidelines for Diagnosis & Management of Viral hepatitis. 2018. Available from: https://www.inasl.org.in/diagnosis-management-viral-hepatitis.pdf. Accessed 403, 2021.
   Google Scholar
• Gupta E, Choudhary MC, Upadhyay N, et al. Lower rates of naturally occurring resistance-associated substitutions (RASs) in hepatitis C virus (HCV)-infected chronic kidney disease (CKD) patients than in HCV-infected patients with only liver disease. Infect Drug Resist. 2019;12:3635–3640. doi:10.2147/IDR.S22033531819546
   PubMed Web of Science ®Google Scholar
• Kalaghatgi P, Sikorski AM, Knops E, et al. Geno2pheno[HCV] - a web-based interpretation system to support hepatitis C treatment decisions in the era of direct-acting antiviral agents. PLoS One. 2016;11(5):e0155869. doi:10.1371/journal.pone.015586927196673
   PubMed Web of Science ®Google Scholar
• Dietz J, Susser S, Vermehren J, et al. Patterns of resistance-associated substitutions in patients with chronic HCV infection following treatment with direct-acting antivirals. Gastroenterology. 2018;154(4):976–988 e974. doi:10.1053/j.gastro.2017.11.00729146520
   PubMed Web of Science ®Google Scholar
• Malta F, Gaspareto KV, Lisboa-Neto G, Carrilho FJ, Mendes-Correa MC, Pinho JRR. Prevalence of naturally occurring NS5A resistance-associated substitutions in patients infected with hepatitis C virus subtype 1a, 1b, and 3a, co-infected or not with HIV in Brazil. BMC Infect Dis. 2017;17(1):716. doi:10.1186/s12879-017-2817-729132303
   PubMed Web of Science ®Google Scholar
• Hezode C, Reau N, Svarovskaia ES, et al. Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir/velpatasvir in the Phase III studies. J Hepatol. 2018;68(5):895–903. doi:10.1016/j.jhep.2017.11.03229221887
   PubMed Web of Science ®Google Scholar
• Li Z, Liu Y, Zhang Y, et al. Naturally occurring resistance-associated variants to hepatitis C virus direct-acting antiviral agents in treatment-naive HCV genotype 6a-infected patients. Biomed Res Int. 2017;2017:9849823.29164151
   PubMed Web of Science ®Google Scholar
• Bagaglio S, Messina E, Hasson H, Galli A, Uberti-Foppa C, Morsica G. Geographic distribution of HCV-GT3 subtypes and naturally occurring resistance associated substitutions. Viruses. 2019;11(2):148. doi:10.3390/v11020148
   PubMed Web of Science ®Google Scholar
• Dalgard O, Weiland O, Noraberg G, et al. Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-a Scandinavian real-life study. PLoS One. 2017;12(7):e0179764. doi:10.1371/journal.pone.017976428704381
   PubMed Web of Science ®Google Scholar